Cardiomyopathy News and Research

RSS

Cardiomyopathy is a group of diseases with primary, usually diffuse, involvement of the myocardium. The myocardial disease is not secondary to ischaemic, valvular, congenital or pericardial disease.

Mayo Clinic surgeon explains the benefits of surgery for hypertrophic cardiomyopathy

Hearing that someone you love may need heart surgery can be scary, especially when you're also trying to understand an unfamiliar heart condition.

21 Oct 2026

You don't need 10,000 steps a day to benefit your heart, cardiologists say

A new American College of Cardiology scientific statement recommends integrating individualized exercise prescriptions into routine cardiovascular care, drawing on evidence supporting aerobic activity, resistance training, and cardiac rehabilitation. The authors emphasize that previously inactive individuals have the most to gain from increasing physical activity, while exercise recommendations should consider individual health conditions, functional capacity, and safety.

18 Oct 2026

A study of 2.3 million California children raises questions about lithium in water

Researchers analyzed healthcare records from more than 2.3 million children in California and found that those living in counties with higher lithium concentrations in water sources had 60% higher adjusted odds of a Wolff-Parkinson-White (WPW) diagnosis. A separate New York analysis supported an association at a lower lithium threshol

14 Oct 2026

County analysis reveals deep geographic and racial heart disease disparities

Despite sustained declines in overall cardiovascular disease mortality in the U.S., disparities based on race, ethnicity and place still persist, with mortality varying far more across counties than states, according to a county-by-cause-by-population analysis published in JACC, the flagship journal of the American College of Cardiology (ACC).

7 Oct 2026

Anti-fibrotic compound alters cell communication by redirecting cellular packages

An experimental anti-fibrotic compound can dramatically alter how cells release the microscopic packages they use to communicate, according to new research from the University of Surrey.

30 Sep 2026

New artificial intelligence model detects tissue damage in the heart

Researchers from the COR group at the Institute of Information and Communications Technologies (ITACA) of the Universitat Politècnica de València (UPV) have developed an artificial intelligence model capable of localizing and quantifying tissue abnormalities associated with atrial cardiomyopathy using electrical recordings from the body's surface.

28 Sep 2026

Why one gut microbe is attracting attention in heart failure research

Researchers found that chronic systolic heart failure caused by nonischemic cardiomyopathy was associated with reduced gut microbial diversity, depletion of Bifidobacterium, and lower microbial short-chain fatty acid production potential. Higher Bifidobacterium abundance and higher circulating indole-3-propionic acid levels were associated with milder disease and clinical improvement, although the findings do not establish causality.

27 Sep 2026

Study identifies shared pathway driving cardiac fibrosis

Three adenosine receptor subtypes that normally send different signals were found to converge on a common pathway that activates cardiac fibroblasts, the scar-forming cells in the heart.

24 Sep 2026

Strength training shows no added arrhythmia risk in people with arrhythmogenic cardiomyopathy

People living with arrhythmogenic cardiomyopathy (ACM), a heritable heart condition that can significantly increase risks for sudden cardiac death, are advised to avoid high-intensity aerobic exercise.

10 Sep 2026

AI learned from cardiologists’ notes, and needed far less labeled ECG data

By teaching an AI system to connect raw heart signals with the clinical insights contained in cardiologists’ reports, researchers tested whether routine ECGs could reveal more with far fewer labeled examples.

2 Sep 2026

Alcohol-related liver cancer deaths were falling. Then the trend reversed during the COVID-19 pandemic

A global analysis of GBD 2023 data found that alcohol-attributable liver cancer mortality increased modestly from 1990 to 2023, while mortality from alcohol-attributable cirrhosis, alcoholic cardiomyopathy, and alcohol use disorders declined. Liver cancer mortality shifted from a pre-pandemic decline to an increase during 2020–2023, particularly among women, although the researchers cautioned that the ecological analysis cannot establish that pandemic-related changes caused the reversal.

1 Sep 2026

ECG-CLIP improves heart disease detection using less labeled data

Clinicians often use a medical test called a 12-lead electrocardiogram (ECG) to diagnose heart problems, which uses electrodes placed on the chest and limbs to record the heart's electrical activity.

1 Sep 2026

Aficamten improves symptom burden and exercise capacity in patients with non-obstructive HCM

Aficamten treatment was associated with significant improvements in symptom burden and exercise capacity in patients with symptomatic non-obstructive hypertrophic cardiomyopathy, according to results presented in a Hot Line session today at ESC Congress 2026 and published simultaneously in the New England Journal of Medicine.

28 Aug 2026

Younger heart patients benefit from implantable cardioverter-defibrillators in CMR GUIDE trial

An implantable cardioverter-defibrillator did not improve the primary endpoint overall in the CMR GUIDE trial but younger patients appeared to benefit, according to results presented in a Hot Line session today at ESC Congress 2026 and published simultaneously in JAMA.

28 Aug 2026

Cardiomyopathy News and Research

Further Reading

Mayo Clinic surgeon explains the benefits of surgery for hypertrophic cardiomyopathy

You don't need 10,000 steps a day to benefit your heart, cardiologists say

A study of 2.3 million California children raises questions about lithium in water

County analysis reveals deep geographic and racial heart disease disparities

Anti-fibrotic compound alters cell communication by redirecting cellular packages

New artificial intelligence model detects tissue damage in the heart

Why one gut microbe is attracting attention in heart failure research

Study identifies shared pathway driving cardiac fibrosis

Strength training shows no added arrhythmia risk in people with arrhythmogenic cardiomyopathy

AI learned from cardiologists’ notes, and needed far less labeled ECG data

Alcohol-related liver cancer deaths were falling. Then the trend reversed during the COVID-19 pandemic

ECG-CLIP improves heart disease detection using less labeled data

Aficamten improves symptom burden and exercise capacity in patients with non-obstructive HCM

Younger heart patients benefit from implantable cardioverter-defibrillators in CMR GUIDE trial

CARDIO-TTRansform trial investigating eplontersen fails to meet primary efficacy endpoint

Review explores complex links between obesity and cardiovascular diseases

New AI spots hypertrophic cardiomyopathy obstruction from standard ultrasounds

Intertwined cellular processes reshape understanding of diabetes

Genetic variants interact to increase early-onset atrial fibrillation risk

Scientists uncover how muscle actin filaments grow and renew themselves

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News